欧洲癌症研究与治疗组织（EORTC）30805号方案：一项III期试验，比较睾丸切除术与睾丸切除术加醋酸环丙孕酮和低剂量己烯雌酚治疗前列腺转移性癌的疗效。 - Suppr | 超能文献

EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.

作者信息

Robinson M R

机构信息

Department of Urology, Pontefract General Infirmary, West Yorkshire, England, U.K.

出版信息

Prog Clin Biol Res. 1988;260:101-10.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.欧洲癌症研究与治疗组织（EORTC）30805号方案：一项III期试验，比较睾丸切除术与睾丸切除术加醋酸环丙孕酮和低剂量己烯雌酚治疗前列腺转移性癌的疗效。

Prog Clin Biol Res. 1988;260:101-10.

2

Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.

Prog Clin Biol Res. 1987;243A:383-90.

3

The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.欧洲癌症研究与治疗组织泌尿生殖系统癌症合作组III期临床试验（方案30805）的最终分析，该试验比较了睾丸切除术、睾丸切除术加醋酸环丙孕酮和低剂量己烯雌酚在前列腺转移性癌治疗中的效果。

Eur Urol. 1995;28(4):273-83.

4

EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.

Prog Clin Biol Res. 1989;303:111-6.

5

Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.醋酸环丙孕酮对比醋酸甲羟孕酮对比己烯雌酚治疗前列腺癌：欧洲癌症研究与治疗组织30761研究结果

Prog Clin Biol Res. 1987;243A:379-82.

6

Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.前列腺癌激素治疗的III期试验经验。I：欧洲癌症研究与治疗组织（EORTC）试验30761和30762的结果。

Prog Clin Biol Res. 1988;260:111-7.

7

Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.

Am J Clin Oncol. 1988;11 Suppl 1:S33-5.

8

Management of metastatic prostatic carcinoma.转移性前列腺癌的管理

Drug Ther Bull. 1986 Nov 3;24(22):85-8.

9

[Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].[前列腺癌的治疗：醋酸甲羟孕酮、己烯雌酚和醋酸环丙孕酮。欧洲癌症研究与治疗组织泌尿生殖协作组随机研究的初步报告]

Arch Esp Urol. 1982 Sep-Oct;35(5):304-11.

10

Is there a best endocrine management of prostatic carcinoma?

Prog Clin Biol Res. 1988;269:147-58.

引用本文的文献

1

Maximal androgen blockade for advanced prostate cancer.晚期前列腺癌的最大雄激素阻断疗法

Cochrane Database Syst Rev. 2000;1999(2):CD001526. doi: 10.1002/14651858.CD001526.